Ireland’s Injury Board Shortchanges Victims on Medical Fees

The Hidden Toll: How Ireland’s Injury Claims System Leaves Victims Paying the Price

In the intricate and often emotionally fraught world of personal injury claims, victims rightly expect a system designed to deliver fairness, transparency, and adequate compensation for their suffering. In Ireland, the Injuries Resolution Board (IRB), formerly the Personal Injuries Assessment Board (PIAB), was established with this very objective in mind. Its mission statement promises a “fair, prompt, and transparent resolution of personal-injuries claims.” Yet, a deep-seated and systemic issue within the IRB’s processes is actively undermining this mission, leaving the very people it was created to protect out of pocket and eroding the fundamental principles of justice. At the heart of this problem lies the board’s arbitrary and opaque handling of fees for essential medical reports, a practice that consistently forces injured claimants to subsidise the cost of their own claims from the damages awarded for their pain and suffering.

This is not a minor administrative quirk; it is a significant financial burden placed upon victims at their most vulnerable. The process, as it stands, creates a perplexing paradox: a claimant must, by law, procure and pay for a medical report to initiate their claim, yet the body overseeing the claim frequently refuses to fully reimburse this mandatory, necessary, and reasonable expense. This practice has given rise to a consistent pattern of shortfalls, where the amount awarded by the IRB for a medical report is less than its actual cost. The difference, often running into hundreds of euros, is silently deducted from the claimant’s general damages. This quiet erosion of compensation is happening daily, without clear explanation, consistent logic, or any apparent oversight. It begs the questions: how has this situation been allowed to develop, why does it persist, and what does it say about the state of access to justice for the ordinary citizen in Ireland?

A Mandatory First Step on a Costly Path

For any individual in Ireland who has suffered a personal injury and wishes to seek compensation, the journey begins not in a courtroom, but with an application to the Injuries Resolution Board. This is a statutory requirement. Central to this application is the submission of a comprehensive medical report. The IRB’s own “Guidance on Medical Reports,” updated as recently as September 2023, is unequivocal on this point. It states that “all applications to PIAB must be accompanied by a medical report” for the application to be considered complete and for the crucial protection of the Statute of Limitations to apply. The guidance specifies this should be a “treating medical report,” prepared by a medical practitioner who has actually treated the claimant for their injuries.

This requirement is entirely logical. The report serves as the foundational evidence, detailing the nature and extent of the injuries and providing a professional medical opinion on which an assessment can be based. The IRB’s rules acknowledge that claimants may need to submit multiple reports from different specialists, all of which will be considered. The system, therefore, is built upon the necessity of these expert documents. Consequently, the board’s guidance addresses the cost, stating it “will consider all fees and expenses submitted” and that those “reasonably and necessarily incurred” will be allowed, either in whole or in part, as the board “in its discretion determines.”

On the surface, this appears to be a fair and flexible system. The language implies that if a cost is both reasonable and necessary, it will be covered. Given that the initial treating doctor’s report is a non-negotiable prerequisite for lodging a claim, it is difficult to conceive of a scenario where its cost would not be considered “necessarily incurred.” Yet it is within the chasm of the board’s “discretion” that the problem festers. Claimants, often guided by their solicitors, obtain these vital reports from their GPs, A&E consultants, orthopaedic surgeons, or other specialists. They pay the invoice for this report upfront, at the very beginning of their claims process. With the IRB’s 2024 annual report citing an average assessment time of 11.2 months, this means a victim is typically out of pocket for this expense for nearly a year before the IRB even begins to decide whether the cost was justified. It is a system that demands an upfront investment from the injured party, with no guarantee of full reimbursement at the end of a long and stressful wait.

A Pattern of Inconsistency and Unexplained Shortfalls

The theoretical fairness of the IRB’s discretionary power crumbles when examined against real-world outcomes. Evidence gathered from legal practice reveals a troubling and persistent pattern of claimants being awarded less than the invoiced cost of their medical reports. A review conducted by a plaintiff personal-injuries solicitor of 103 of her own client files, all opened since the introduction of the Personal Injury Guidelines in April 2021, provides a stark illustration. Of the cases that proceeded to an assessment by the IRB, a staggering 51—almost exactly half—resulted in the claimant being awarded a lower figure for their medical report fee than the amount they had actually paid.

Crucially, in none of these 51 instances was any reason, rationale, or explanation provided for the shortfall. The assessment simply contained a reduced figure, leaving both the claimant and their legal representative to speculate as to the reasoning. This lack of transparency is compounded by a startling lack of consistency. The analysis revealed that reports from the very same medical consultant, with the same fee, would be treated differently in separate assessments. For example, one A&E consultant’s report costing €500 was allowed at €400 in two assessments, yet was valued at €492 in a third. An orthopaedic consultant’s report, also costing €500, was fully allowed in one case but inexplicably reduced to €400 in another. The discrepancies can be even more dramatic; a plastic surgeon’s report costing €1,230 was reimbursed at €738 in one assessment and just €600 in another.

This arbitrary approach creates an environment of uncertainty and unfairness. Legal professionals familiar with the costs adjudication process would expect a €500 fee for a report from an A&E or orthopaedic consultant to be considered reasonable and recoverable in full. While a higher-cost report from a plastic surgeon might be subject to some reduction in a formal taxation of costs, the wild and unexplained variance in the IRB’s assessments suggests a system operating without a clear, guiding methodology. It appears to be less a considered exercise of discretion and more a lottery, where the value of a necessary expense is determined by opaque internal metrics or the whim of an individual assessor on any given day.

Inside the Black Box: The IRB’s Outdated Rulebook

In an effort to penetrate this opacity and understand the basis for these decisions, a request was made to the IRB under the Freedom of Information (FOI) Acts, seeking all guidelines, policies, and training materials used by assessors to determine awards for claimants’ medical report fees. The response was illuminating, not for its sophistication, but for its stark inadequacy. The core document provided was a set of “Guidelines in relation to assessing the amount to be allowed for medical reports submitted by Claimants,” dated 1 February 2019. This document, now over five years old, remains the primary tool used by IRB assessors.

The 2019 guidelines establish a grid of expected cost ranges for reports from various medical specialities. These figures, which are net of VAT, include: up to €350 for a GP or dentist; up to €400 for an A&E consultant or general surgeon; up to €500 for an orthopaedic specialist; up to €600 for a plastic surgeon; up to €650 for a psychiatrist; and up to €750 for a neurosurgeon. The guidelines also provide for lower amounts, from €120 to €175 for a limited letter-style report, and a mere €45 to €75 for a simple note confirming injuries.

The most glaring issue with these guidelines is their age. In the years since February 2019, the Irish economy has experienced significant inflation, and the cost of professional services, including specialist medical consultations and administrative work, has risen accordingly. Any personal injury solicitor can attest that the cost of obtaining medico-legal reports has increased substantially in that time. Yet the IRB continues to anchor its assessments to a fee structure that is demonstrably out of touch with current market rates. This failure to review and update its own internal benchmarks guarantees that shortfalls will be a common occurrence, not an exception.

A further FOI request seeking any documentation related to the use of discretion by staff in applying these guidelines yielded nothing, suggesting there are no further formal rules or training to guide assessors on how to handle cases where costs exceed these outdated thresholds. The system appears rigid and unresponsive, forcing assessors to either adhere to an obsolete fee grid or make ad-hoc decisions without a clear framework, leading directly to the inconsistencies observed in practice.

A Tale of Two Standards: Protecting a Panel, Penalising a Claimant

The IRB’s parsimonious approach to claimants’ expenses is thrown into even sharper relief when contrasted with its handling of its own medical report fees. As part of its assessment process, the IRB frequently commissions its own independent medical reports from a panel of approved practitioners. The cost of these reports is paid by the IRB and then fully reimbursed by the respondent (typically an insurance company) as part of the process. The IRB’s 2024 annual report shows a figure of €7,891,081 due to be reimbursed for these reports, an increase from the previous year. This demonstrates that the board has no issue with, and indeed demands, the full recovery of medical report costs when it is the commissioning party.

This creates a deeply inequitable double standard. The IRB effectively insists that the costs incurred by its own chosen panel of medical experts are non-negotiable and must be paid in full by respondents. Simultaneously, it reserves the right to arbitrarily reduce the costs incurred by the injured claimant for a report from their own treating doctor—a report that is mandatory to even access the system. The injustice is palpable: the board protects the financial interests of its professional service providers while penalising the victim.

The disparity is further shrouded in secrecy. An FOI request for the fee structure paid to the IRB’s independent medical panel was refused under section 36(1)(b) of the FOI Act, on the grounds that it was commercially sensitive information that could prejudice the competitive position of the medical practitioners on the panel. While the protection of commercial sensitivity is a valid tenet of FOI law, its application here is deeply ironic. The IRB is willing to use this provision to shield the fee arrangements of its own contracted experts from public scrutiny, yet it offers no such consideration or protection to the individual claimant, who has no bargaining power and must simply accept the fee quoted by their treating doctor to get their claim off the ground. This selective transparency fosters suspicion that the fees paid to the IRB’s own panel may well exceed the amounts it deems “reasonable” for claimants to incur.

A System Without Oversight: The Data Deficit

Perhaps the most damning indictment of the IRB’s approach is the systemic failure to monitor or even properly record the issue. The board has confirmed that it does not log the amount of the medical report fee *claimed* by the claimant on its main operating system. This information is noted manually on an individual case file document but is not captured in a way that allows for data analysis. Consequently, the IRB cannot generate any reports on the scale of the problem. It holds no records on the percentage of claimants who are awarded their full medical report costs. It holds no data on the average shortfall suffered by those who are not. It has no records of any internal discussions, considerations, or reviews of its own 2019 guidelines since they were first implemented.

This is not merely a technical limitation; it is a profound failure of governance and oversight. An organisation committed to fairness would surely want to track the financial impact of its discretionary decisions on claimants. The absence of such data suggests an institutional indifference to the issue. If the problem is not measured, it cannot be managed, and it appears the IRB has made no effort to measure it. The only related data point available, obtained via an FOI request, is the average amount *awarded* to claimants for their medical reports, which from April 2024 to March 2025 stood at €373. While this figure seems low when compared to the known costs of specialist reports, its true significance is impossible to gauge without the corresponding data on the average amount claimed. It is a statistic in a vacuum, revealing little but reinforcing the sense of a system operating without accountability.

The Human Cost and an Urgent Call for Reform

Ultimately, this is not an abstract procedural debate. It has a real and detrimental impact on injured people. When the IRB reduces the award for a medical report fee, the claimant is left with a choice: either abandon their claim or accept an assessment that forces them to pay the difference. This shortfall is invariably paid from their general damages—the very money awarded to them as compensation for their physical pain, their psychological trauma, and the impact the injury has had on their quality of life. In essence, compensation intended to make the victim whole is being diverted to cover a basic, necessary, and legally required administrative cost of their claim.

The practice is particularly nonsensical in cases involving infants. Any assessment for a minor, if accepted, must be brought before a court for approval in a process known as a ruling. In these proceedings, a judge will almost invariably award the full, vouched cost of the medical reports as part of the legal costs. The IRB’s initial reduction of these fees in the assessment serves no purpose other than to create an unnecessary discrepancy that is later corrected by the courts, adding a layer of pointless bureaucracy to the process.

The current state of affairs is untenable. The IRB’s assessment of section 44 medical report fees is arbitrary, lacks transparency, and is based on outdated and inadequate guidelines. It creates an unjust double standard and places a financial penalty on injury victims. This situation demands an immediate statutory review. As a matter of principle, at least one full treating medical report fee should be awarded in every assessment, unless there are exceptional and clearly articulated reasons in the interests of justice to do otherwise.

Any discretion retained by the IRB must be governed by clear, modern, and publicly available rules. Assessors must receive proper training, and both claimants and the medical practitioners who provide these vital reports should be made fully aware of the board’s approach. Furthermore, the recovery of these fees must be continuously monitored, with data on claim amounts versus awards published in the IRB’s annual report. This is not just a matter of financial accounting; it is a key metric for gauging access to justice.

Highlighting this issue is a necessary step towards change. The alternative is a grim one: a vulnerable claimant is eventually forced to become a test case, launching a costly and high-risk High Court challenge to rectify a systemic wrong. Reform should not depend on the courage and financial sacrifice of one individual. It is the responsibility of the system itself to be fair. The band-aid has been torn off; it is now up to policymakers and the IRB to properly treat the wound.